215
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Development of medicated chewing gum of taste masked levocetirizine dihydrochloride using different gum bases: in vitro and in vivo evaluation

, &
Pages 395-402 | Received 09 Aug 2019, Accepted 26 Jan 2020, Published online: 09 Feb 2020

References

  • Al Hagbani T, Nazzal S. Medicated chewing gums (MCGs): composition, production, and mechanical testing. AAPS PharmSciTech. 2018;19(7):2908–2920.
  • Shete RB, Muniswamy VJ, Pandit AP, et al. Formulation of eco-friendly medicated chewing gum to prevent motion sickness. AAPS PharmSciTech. 2015;16(5):1041–1050.
  • Akbal Ö, Cevher E, Araman AO. The development and in vitro evaluation of benzydamine hydrochloride medicated chewing gum formulations. Istanbul J Pharm. 2017;47(2):45–51.
  • Samvedna S, Jindal S, Mishra G, et al. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. Polim Med. 2018;48(1):31–40.
  • Labib GS. Novel levocetirizine HCl tablets with enhanced palatability: synergistic effect of combining taste modifiers and effervescence technique. Drug Des Dev Ther. 2015;9:5135–5146.
  • Ali J, Zgair A, Hameed GS, et al. Application of biorelevant saliva-based dissolution for optimisation of orally disintegrating formulations of felodipine. Int J Pharm. 2019;555:228–236.
  • Sharma M, Soni R. Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study. Sci Rep. 2018;8(1):2812.
  • Wang L, Sun Y, Kuang C, et al. Preparation and evaluation of taste masked oral suspension of arbidol hydrochloride. Asian J Pharm Sci. 2015;10(1):73–79.
  • Kelemen H, Hancu G, Gâz-Florea SA, et al. Characterization of inclusion complexes between miconazole and different cyclodextrin derivatives. Acta Med Marisiensis. 2018;64(2):70–76.
  • Paradkar M, Gajra B, Patel B. Formulation development and evaluation of medicated chewing gum of anti-emetic drug. Saudi Pharm J. 2016;24(2):153–164.
  • Aslani A, Ghannadi A, Rostami F. Design, formulation, and evaluation of ginger medicated chewing gum. Adv Biomed Res. 2016;5(1):130.
  • Khan H, Ahmed K, Maheen S, et al. Development and characterization of novel antihypertensive medicated chewing gum. Int J Biol Pharm Allied Sci. 2015;4(11):6264–6280.
  • Vasudha LS, Yadav HK, Mahesh KP, et al. Formulation and evaluation of medicated chewing gum as antiplaque and antibacterial agent. J Young Pharm. 2014;6(4):3.
  • Kvist LC, Andersson SB, Berglund J, et al. Equipment for drug release testing of medicated chewing gums. J Pharm Biomed. 2000;22(3):405–411.
  • Attar AH, Gawade DS. Formulation and evaluation of medicated chewing gum containing caffeine salicylate. Asian J Pharm Technol Innov. 2015;3(10):43–53.
  • Rajitha K, Rao YM. Formulation and evaluation of medicated chewing gum of chlorpheniramine maleate by melting method. World J Pharm Pharm Sci. 2016;5(5):1322–1329.
  • Nagaich U, Chaudhary V, Karki R, et al. Formulation of medicated chewing gum of ondansetron hydrochloride and its pharmacokinetic evaluations. Int J Pharm Sci. 2010;1:32–40.
  • Mohammadi N, Ehsani MR, Bakhoda H. Characterization of Saqez as a natural chewing gum. J Therm Anal Calorim. 2019;137(3):825–829.
  • Vila MM, Tardelli ER, Chaud MV, et al. Development of a buccal mucoadhesive film for fast dissolution: mathematical rationale, production and physicochemical characterization. Drug Deliv. 2014;21(7):530–539.
  • Jeziorska R, Szadkowska A, Spasowka E, et al. Characteristics of biodegradable polylactide/thermoplastic starch/nanosilica composites: effects of plasticizer and nanosilica functionality. Adv Mater Sci Eng. 2018;2018:1–15.
  • Khatri P, Desai D, Minko T. On the plasticizing properties of divalproex sodium: physicochemical and spectroscopic characterization studies. Pharm Dev Technol. 2019;24(4):455–464.
  • Garg M, Naidu R, Iyer K, et al. Bioequivalence of two different nicotine chewing gum formulations of two different strengths (2 mg and 4 mg) in Indian healthy adult human male smoker subjects. J Bioequiv Bioavailab. 2016;8(2):74–79.
  • Morita MR, Berton D, Boldin R, et al. Determination of levocetirizine in human plasma by liquid chromatography–electrospray tandem mass spectrometry: application to a bioequivalence study. J Chromatogr B. 2008;862(1–2):132–139.
  • Ino H, Hara K, Honma G, et al. Comparison of levocetirizine pharmacokinetics after single doses of levocetirizine oral solution and cetirizine dry syrup in healthy Japanese male subjects. J Drug Assess. 2014;3(1):38–42.
  • Du D. A single-dose, crossover-design bioequivalence study comparing two nicotine gum formulations in healthy subjects. Adv Ther. 2018;35(8):1169–1180.
  • Chay SK, Keating AV, James C, et al. Evaluation of the taste-masking effects of (2-hydroxypropyl)-β-cyclodextrin on ranitidine hydrochloride; a combined biosensor, spectroscopic and molecular modelling assessment. RSC Adv. 2018;8(7):3564–3573.
  • Abraham JI, Mathew FL. Taste masking of paediatric formulation: a review on technologies, recent trends and regulatory aspects. Int J Pharm Pharm Sci. 2014;6(1):12–19.
  • Yewale CP, Rathi MN, Kore GG, et al. Formulation and development of taste masked fast-disintegrating tablets (FDTs) of chlorpheniramine maleate using ion-exchange resins. Pharm Dev Technol. 2013;18(2):367–376.
  • Malaquias LF, Sá-Barreto LC, Freire DO, et al. Taste masking and rheology improvement of drug complexed with beta-cyclodextrin and hydroxypropyl-β-cyclodextrin by hot-melt extrusion. Carbohydr Polym. 2018;185:19–26.
  • Geng Q, Li T, Wang X, et al. The mechanism of bensulfuron-methyl complexation with β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin and effect on soil adsorption and bio-activity. Sci Rep. 2019;9(1):1882.
  • Sivaneswari S, Karthikeyan E, Veena D, et al. Physiochemical characterization of taste masking levetiracetam ion exchange resinates in the solid state and formulation of stable liquid suspension for pediatric use. Beni-Suef Univ J Basic Appl Sci. 2016;5(2):126–133.
  • Jia P, Xia H, Tang K, et al. Plasticizers derived from biomass resources: a short review. Polymers. 2018;10(12):1303.
  • Menčík P, Přikryl R, Stehnová I, et al. Effect of selected commercial plasticizers on mechanical, thermal, and morphological properties of poly(3-hydroxybutyrate)/poly(lactic acid)/plasticizer biodegradable blends for three-dimensional (3D) print. Materials. 2018;11(10):1893.
  • Patel Y, Shukla A, Saini V, et al. Chewing gum as a drug delivery system. Int J Pharm Sci. 2011;2(4):748.
  • Otoni CG, Avena‐Bustillos RJ, Azeredo HM, et al. Recent advances on edible films based on fruits and vegetables — a review. Compr Rev Food Sci Food Saf. 2017;16(5):1151–1169.
  • Sanyang ML, Sapuan SM, Jawaid M, et al. Effect of plasticizer type and concentration on physical properties of biodegradable films based on sugar palm (Arenga pinnata) starch for food packaging. J Food Sci Technol. 2016;53(1):326–336.
  • Aslani A, Rostami F. Medicated chewing gum, a novel drug delivery system. J Res Med Sci. 2015;20(4):403.
  • Sengel-Turk CT, Hascicek C, Gonul N. Ethylcellulose-based matrix-type microspheres: influence of plasticizer ratio as pore-forming agent. AAPS PharmSciTech. 2011;12(4):1127–1135.
  • Stojanov M, Larsen KL. Cetirizine release from cyclodextrin formulated compressed chewing gum. Drug Dev Ind Pharm. 2012;38(9):1061–1067.
  • Zieschang L, Klein M, Krämer J, et al. In vitro performance testing of medicated chewing gums. Dissolut Technol. 2018;25(3):64–69.
  • Mayhew EJ, Schmidt SJ, Schlich P, et al. Temporal texture profile and identification of glass transition temperature as an instrumental predictor of stickiness in a caramel system. J Food Sci. 2017;82(9):2167–2176.
  • Jadhav NR, Gaikwad VL, Nair KJ, et al. Glass transition temperature: basics and application in pharmaceutical sector. Asian J Pharm. 2009;3(2):82–89.
  • Fortunati E, Puglia D, Iannoni A, et al. Processing conditions, thermal and mechanical responses of stretchable poly(lactic acid)/poly(butylene succinate) films. Materials. 2017;10(7):809.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.